CN102743628A - 一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 - Google Patents
一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 Download PDFInfo
- Publication number
- CN102743628A CN102743628A CN2012102077278A CN201210207727A CN102743628A CN 102743628 A CN102743628 A CN 102743628A CN 2012102077278 A CN2012102077278 A CN 2012102077278A CN 201210207727 A CN201210207727 A CN 201210207727A CN 102743628 A CN102743628 A CN 102743628A
- Authority
- CN
- China
- Prior art keywords
- gram
- herba
- grams
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000008961 swelling Effects 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 206010007882 Cellulitis Diseases 0.000 title claims abstract description 25
- 239000006210 lotion Substances 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 241001116779 Lemmaphyllum Species 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- 241001164374 Calyx Species 0.000 claims description 6
- 241000382923 Oxya chinensis Species 0.000 claims description 6
- 244000064622 Physalis edulis Species 0.000 claims description 6
- 241001140314 Plestiodon chinensis Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 241001505096 Rhamnus davurica Species 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000002411 adverse Effects 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 241000522190 Desmodium Species 0.000 abstract 3
- 206010042674 Swelling Diseases 0.000 abstract 3
- 241000748223 Alisma Species 0.000 abstract 1
- 241000512005 Alstonia Species 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 241000405421 Breynia Species 0.000 abstract 1
- 244000062995 Cassia occidentalis Species 0.000 abstract 1
- 235000001948 Cassia occidentalis Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000598860 Garcinia hanburyi Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000735470 Juncus Species 0.000 abstract 1
- 241000745390 Lophatherum Species 0.000 abstract 1
- 235000013939 Malva Nutrition 0.000 abstract 1
- 240000000982 Malva neglecta Species 0.000 abstract 1
- 235000000060 Malva neglecta Nutrition 0.000 abstract 1
- 244000050427 Melilotus officinalis subsp suaveolens Species 0.000 abstract 1
- 235000000839 Melilotus officinalis subsp suaveolens Nutrition 0.000 abstract 1
- 244000187664 Nerium oleander Species 0.000 abstract 1
- 240000007817 Olea europaea Species 0.000 abstract 1
- 240000007019 Oxalis corniculata Species 0.000 abstract 1
- 235000016499 Oxalis corniculata Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000424774 Plagiorhegma dubium Species 0.000 abstract 1
- 244000086956 Polygonum perfoliatum Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000219093 Rhamnus Species 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 241000931191 Scincidae Species 0.000 abstract 1
- 241000220286 Sedum Species 0.000 abstract 1
- 235000000340 Solanum pseudocapsicum Nutrition 0.000 abstract 1
- 240000007641 Spergula rubra Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000205578 Thalictrum Species 0.000 abstract 1
- 244000058281 Ulmus pumila Species 0.000 abstract 1
- 235000001547 Ulmus pumila Nutrition 0.000 abstract 1
- 241001278775 Veronicastrum Species 0.000 abstract 1
- 240000004922 Vigna radiata Species 0.000 abstract 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 abstract 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 abstract 1
- 240000001417 Vigna umbellata Species 0.000 abstract 1
- 235000011453 Vigna umbellata Nutrition 0.000 abstract 1
- 240000004482 Withania somnifera Species 0.000 abstract 1
- 235000001978 Withania somnifera Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229940117709 gamboge Drugs 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 description 36
- 230000035619 diuresis Effects 0.000 description 36
- 231100000614 poison Toxicity 0.000 description 34
- 239000003440 toxic substance Substances 0.000 description 28
- 235000009508 confectionery Nutrition 0.000 description 24
- 210000004072 lung Anatomy 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 21
- 210000002784 stomach Anatomy 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 19
- 206010007247 Carbuncle Diseases 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 15
- 210000002216 heart Anatomy 0.000 description 14
- 230000001939 inductive effect Effects 0.000 description 13
- 210000003932 urinary bladder Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000002429 large intestine Anatomy 0.000 description 12
- 208000033809 Suppuration Diseases 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 2
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 2
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940038649 clavulanate potassium Drugs 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Abstract
Description
年龄(岁) | 25~30 | 31~40 | 41~50 | 51~60 |
例数 | 15 | 235 | 132 | 3 |
百分比 | 3.9% | 61% | 34.3% | 0.8% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 383 | 2 | 无 |
百分比 | 99.5% | 0.5% | 无 |
治疗天数 | 3~5 | 6~9 | 10~14 | 15~20 |
例数 | 62 | 195 | 121 | 7 |
百分比 | 16.1% | 50.7% | 31.4% | 1.8% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210207727.8A CN102743628B (zh) | 2012-06-24 | 2012-06-24 | 一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210207727.8A CN102743628B (zh) | 2012-06-24 | 2012-06-24 | 一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102743628A true CN102743628A (zh) | 2012-10-24 |
CN102743628B CN102743628B (zh) | 2014-03-12 |
Family
ID=47024357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210207727.8A Expired - Fee Related CN102743628B (zh) | 2012-06-24 | 2012-06-24 | 一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102743628B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103099990A (zh) * | 2013-02-09 | 2013-05-15 | 王霞 | 一种治疗结块型急性乳腺炎的中药洗剂制备方法 |
CN103432450A (zh) * | 2013-08-22 | 2013-12-11 | 岳冀 | 一种治疗肿胀型急性颈部淋巴结炎的中药制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309699A (zh) * | 2010-06-30 | 2012-01-11 | 张红旗 | 一种治疗颈部蜂窝组织炎的中药方 |
CN102327396A (zh) * | 2011-09-19 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | 治疗蜂窝组织炎的中草药 |
-
2012
- 2012-06-24 CN CN201210207727.8A patent/CN102743628B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309699A (zh) * | 2010-06-30 | 2012-01-11 | 张红旗 | 一种治疗颈部蜂窝组织炎的中药方 |
CN102327396A (zh) * | 2011-09-19 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | 治疗蜂窝组织炎的中草药 |
Non-Patent Citations (2)
Title |
---|
国家药品监督管理局: "关于取消关木通药用标准的通知", 《HTTP://WWW.SDA.GOV.CN/WS01/CL0844/9977.HTML》, 1 April 2003 (2003-04-01), pages 1 * |
杜章凤: "爵床粉配芙蓉膏治疗蜂窝组织炎206例", 《四川中医》, vol. 18, no. 6, 31 December 2000 (2000-12-31), pages 45 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103099990A (zh) * | 2013-02-09 | 2013-05-15 | 王霞 | 一种治疗结块型急性乳腺炎的中药洗剂制备方法 |
CN103432450A (zh) * | 2013-08-22 | 2013-12-11 | 岳冀 | 一种治疗肿胀型急性颈部淋巴结炎的中药制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102743628B (zh) | 2014-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102743633B (zh) | 一种治疗腐肉型蜂窝组织炎的中药洗剂制备方法 | |
CN102743630B (zh) | 一种治疗嗜食大蒜型蜂窝组织炎的中药洗剂制备方法 | |
CN102743565B (zh) | 一种治疗焮红型蜂窝组织炎的中药洗剂制备方法 | |
CN102743651B (zh) | 一种治疗溲赤型蜂窝组织炎的中药洗剂制备方法 | |
CN102743636B (zh) | 一种治疗热毒型蜂窝组织炎的中药洗剂制备方法 | |
CN102743632B (zh) | 一种治疗便秘型蜂窝组织炎的中药洗剂制备方法 | |
CN102743592B (zh) | 一种治疗结块型蜂窝组织炎的中药洗剂制备方法 | |
CN102743696B (zh) | 一种治疗血瘀型蜂窝组织炎的中药洗剂制备方法 | |
CN102743628B (zh) | 一种治疗肿胀型蜂窝组织炎的中药洗剂制备方法 | |
CN102743629B (zh) | 一种治疗脓水型蜂窝组织炎的中药洗剂制备方法 | |
CN103110837B (zh) | 一种治疗热毒内蕴型角膜实质炎的中药制备方法 | |
CN102743698B (zh) | 一种治疗疼痛型蜂窝组织炎的中药洗剂制备方法 | |
CN102631578B (zh) | 一种治疗水肿型足底疔的中药洗剂制备方法 | |
CN102743637B (zh) | 一种治疗发热型蜂窝组织炎的中药洗剂制备方法 | |
CN102743650B (zh) | 一种治疗吸烟型蜂窝组织炎的中药洗剂制备方法 | |
CN102743631B (zh) | 一种治疗酗酒型蜂窝组织炎的中药洗剂制备方法 | |
CN102743726B (zh) | 一种治疗气血虚弱型蜂窝组织炎的中药洗剂制备方法 | |
CN103099990A (zh) | 一种治疗结块型急性乳腺炎的中药洗剂制备方法 | |
CN102631576B (zh) | 一种治疗便秘型足底疔的中药洗剂制备方法 | |
CN102743566A (zh) | 一种治疗搔痒型蜂窝组织炎的中药洗剂制备方法 | |
CN103110856A (zh) | 一种治疗发热型急性乳腺炎的中药洗剂制备方法 | |
CN102743593B (zh) | 一种治疗嗜食辣椒型蜂窝组织炎的中药洗剂制备方法 | |
CN102631575B (zh) | 一种治疗热毒型足底疔的中药洗剂制备方法 | |
CN102631577B (zh) | 一种治疗溲赤型足底疔的中药洗剂制备方法 | |
CN102743697B (zh) | 一种治疗肝火炽盛型蜂窝组织炎的中药洗剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANG LI Free format text: FORMER OWNER: DONG HUIPING Effective date: 20140207 |
|
CB03 | Change of inventor or designer information |
Inventor after: Zhang Li Inventor before: Dong Huiping |
|
CB03 | Change of inventor or designer information | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272111 JINING, SHANDONG PROVINCE TO: 271200 TAIAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: DONG HUIPING TO: ZHANG LI |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140207 Address after: Tai'an City, Shandong province 271200 orthopedics Peoples Hospital of Xintai City Applicant after: Zhang Li Address before: No. 28 Jining 272111 Shandong orthopedics hospital of Jining City Central City Road Applicant before: Dong Huiping |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140312 Termination date: 20140624 |
|
EXPY | Termination of patent right or utility model |